Pharma Journalist -

AstraZeneca has received approval from the U.S. Food and Drug Administration for a new self-administered version of its lupus treatment, Saphnelo, marking a significant step forward in…
Read More...

BioMarin Pharmaceutical Inc. has finalized its acquisition of Amicus Therapeutics in an all-cash deal valued at approximately $4.8 billion, marking a significant expansion of its rare…
Read More...

Sun Pharmaceutical Industries Limited has announced a landmark agreement to acquire Organon & Co. in an all-cash transaction valued at approximately $11.75 billion. Under the terms…
Read More...

Leinco Technologies and CellCarta have announced a strategic collaboration to enhance proteomics solutions aimed at supporting immuno-oncology research and the development of targeted…
Read More...

Cipla Limited and its wholly owned subsidiary Cipla USA Inc. have secured final approval from the U.S. Food and Drug Administration (USFDA) for their Abbreviated New Drug Application…
Read More...

Radiopharmaceuticals continue to reshape oncology strategy. Regeneron’s entry into radiopharma through its partnership with Telix investing $40M upfront across up to four oncology…
Read More...

MSD, known as Merck & Co., Inc. in the United States, has entered into a major multi-year partnership with Google Cloud aimed at transforming the pharmaceutical giant into a fully…
Read More...

AbbVie has announced a major $1.4 billion investment to establish a new pharmaceutical manufacturing campus in Durham, marking a significant expansion of its U.S. production…
Read More...

Clinical-stage biotech firm BioAegis Therapeutics has entered a strategic collaboration with Prenosis to accelerate the development of a precision medicine approach for inflammatory…
Read More...

The U.S. Food and Drug Administration has approved IDVYNSO, a new once-daily, single-tablet regimen developed by Merck, for the treatment of adults living with HIV-1. The therapy is…
Read More...